Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 May;25(5):407-411.
doi: 10.3348/kjr.2024.0016. Epub 2024 Apr 11.

Summary of Key Points of the Response Assessment in Neuro-Oncology (RANO) 2.0

Sang Eun Won #  1 , Chong Hyun Suh #  2 , Sinae Kim  1 , Hyo Jung Park  2 , Kyung Won Kim  3
Affiliations
Editorial

Summary of Key Points of the Response Assessment in Neuro-Oncology (RANO) 2.0

Sang Eun Won et al. Korean J Radiol. 2024 May.
No abstract available

Keywords: Gliomas; Imaging response assessment; RANO 2.0.

PubMed Disclaimer

Conflict of interest statement

Chong Hyun Suh, who hold respective positions on the Assistants to the Editor of the Korean Journal of Radiology, were not involved in the editorial evaluation or decision to publish this article. The remaining author has declared no conflicts of interest.

Figures

Fig. 1
Fig. 1. Evolution of imaging response assessment for gliomas. HGG = high-grade glioma, RANO = Response Assessment in Neuro-Oncology, LGG = low-grade glioma, iRANO = immunotherapy RANO, mRANO = modified RANO
Fig. 2
Fig. 2. Response assessment scheme. CCRT = concomitant chemoradiotherapy, RT = radiation tehrapy, PD = progression disease, SD = stable disease, PR = partial response, CR = complete response, RANO = Response Assessment in Neuro-Oncology, RANO-HGG = RANO for high-grade glioma, iRANO = immunotherapy RANO
See this image and copyright information in PMC

Comment in

References

    1. Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E, et al. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol. 2010;28:1963–1972. - PubMed
    1. van den Bent MJ, Wefel JS, Schiff D, Taphoorn MJ, Jaeckle K, Junck L, et al. Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas. Lancet Oncol. 2011;12:583–593. - PubMed
    1. Ellingson BM, Wen PY, Cloughesy TF. Modified criteria for radiographic response assessment in glioblastoma clinical trials. Neurotherapeutics. 2017;14:307–320. - PMC - PubMed
    1. Okada H, Weller M, Huang R, Finocchiaro G, Gilbert MR, Wick W, et al. Immunotherapy response assessment in neuro-oncology: a report of the RANO working group. Lancet Oncol. 2015;16:e534–e542. - PMC - PubMed
    1. Wen PY, van den Bent M, Youssef G, Cloughesy TF, Ellingson BM, Weller M, et al. RANO 2.0: update to the response assessment in neuro-oncology criteria for high- and low-grade gliomas in adults. J Clin Oncol. 2023;41:5187–5199. - PMC - PubMed

Publication types